ELYM Stock: Eliem Therapeutics, Inc. Stock Price, Analysis & Insights

Get live ELYM stock price $5.11, comprehensive Eliem Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time ELYM stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

5.11

0.97%Today

ELYM • Eliem Therapeutics, Inc. • NASDAQ Global Market • Healthcare

Market Cap

342.68M

Volume

802.69K

52W High

11.55

52W Low

2.35

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing therapeutic solutions for conditions characterized by abnormal neuronal excitability. The company aims to fulfill significant unmet medical needs in areas such as c...

Contact Information

Website: https://www.eliemtx.com
Address: 23515 NE Novelty Hill Road
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -0.38) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Eliem Therapeutics, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Eliem Therapeutics, Inc.
⚠Investors should consider how Eliem Therapeutics, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

342.68M

P/E Ratio (TTM)

-2.30

Beta

-0.38

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare ELYM with peer companies:

Checkpoint Therapeutics, Inc. (CKPT)

Price: $4.26
Market cap: 367.72M

G1 Therapeutics, Inc. (GTHX)

Price: $7.16
Market cap: 377.75M

Inozyme Pharma, Inc. (INZY)

Price: $4.00
Market cap: 258.25M

iTeos Therapeutics, Inc. (ITOS)

Price: $10.15
Market cap: 448.68M

Orchard Therapeutics plc (ORTX)

Price: $16.70
Market cap: 380.11M

Revance Therapeutics, Inc. (RVNC)

Price: $3.65
Market cap: 381.02M

scPharmaceuticals Inc. (SCPH)

Price: $5.67
Market cap: 302.20M

Alaunos Therapeutics, Inc. (TCRT)

Price: $1.97
Market cap: 4.81M

Vigil Neuroscience, Inc. (VIGL)

Price: $8.05
Market cap: 375.71M

Y-mAbs Therapeutics, Inc. (YMAB)

Price: $8.61
Market cap: 391.22M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.